Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report - Top-Institutions - MDSpire

Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report

  • By

  • Yuqiang Zhou

  • Zhiliang Zhang

  • Shasha Liu

  • Jiang Nan

  • Zhuoli Zhang

  • Zixian Chen

  • June 3, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Brigham Health System
    Massachusetts General Brigham Health System

    Boston, MA

    Key Differentiators

    • Cardiology
    • Oncology

  • #2

    Stephenson Cancer Center
    Stephenson Cancer Center

    Oklahoma City, OK

    Key Differentiators

    • Oncology

  • #3

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Transplant Surgery

Original Source(s)

Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report

  • by Yuqiang Zhou, Zhiliang Zhang, Shasha Liu, Jiang Nan, Zhuoli Zhang, Zixian Chen

  • June 3, 2026

Related Content

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU

Is Kaposi’s sarcoma the end of the OX40/OX40L axis in atopic dermatitis?

Mass Spec Roundup: Molecules, Messages and Fingermarks

Mass spectrometry connects searchable metabolites, engineered protein messages, tetrameric p53 binding, and the chemistry of overlapping fingermarks… 

  • June 3, 2026

  • 6 min